Gere Sunder–Plassmann

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

Atul Mehta, Renato Pietro Ricci, Urs Widmer et al. · European Journal of Clinical Investigation · 2004 · 852 citations · Full text

Life Sciences, Biochemistry, Clinical Sciences +12

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 514 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis

Renate Kain, Markus Exner, Ricarda Brandes et al. · Nature Medicine · 2008 · 456 citations · Full text

Medicine, Immunology, Pathology +14

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey

Aleš Linhart, Christoph Kampmann, José Luis Zamorano et al. · European Heart Journal · 2007 · 392 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

Derralynn Hughes, Suma P. Shankar, Gere Sunder–Plassmann et al. · Journal of Medical Genetics · 2016 · 386 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17